WHO ICTRP trial
Efficacy, safety and tolerability of lacosamide in patients with…
NL-OMON41621 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON41621 |
|---|---|
| Public title | Efficacy, safety and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutations related small fiber neuropathy: a randomized, double-blind, placebo controlled, crossover trial |
| Scientific title | Efficacy, safety and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutations related small fiber neuropathy: a randomized, double-blind, placebo controlled, crossover trial - MaYa-Nav1.7 study |
| Primary sponsor | Medisch Universitair Ziekenhuis Maastricht |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational non invasive |
| Phase | 3 |
| Countries | The Netherlands |
| Conditions | peripheral nerve disorder Small fiber neuropathy;10034606;peripheral nerve disorder;Small fiber neuropathy |
| Interventions | ;lacosamide;Nav1.7 mutations;small fiber neuropathy |
| Registration date | Dec 21, 2015 |
| Target size | 20 |
| Secondary IDs | 2013-001511-70;NCT01911975;NL44313.068.13 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: